Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Quantitative and functional characteristics of endothelial progenitor cells in newly diagnosed hypertensive patients

Subjects

Abstract

Populations of peripheral blood CD34+ cells comprise precursors of endothelial cells. These precursors are crucial to cardiovascular homeostasis. Hypertension, as one of the main risk factors for cardiovascular disease, is associated with the loss of endothelium structural integrity and its functional impairment. The aim of our study was to evaluate the subsets of endothelial precursor cells in patients with newly diagnosed arterial hypertension. Twenty-four newly diagnosed, previously untreated hypertensive patients aged 59.5±12.5 years, were enrolled into the study group, whereas the control group comprised 45 healthy subjects, 55.5±10.0 years old. Endothelial progenitor cells (EPCs) were analysed by flow cytometry. The results showed that hypertensive patients were characterized by a significantly higher percentage and number of the CD34+ cells and simultaneously less differentiated CD34+CD45dim/negCD133+ progenitors. The percentage and number of CD34+CD45negVEGFR2+ and CD34+CD45negCD133+VEGFR2+ cells were not different from the control group. Moreover, patients had a significantly lower percentage and number of the CD34+CD45negVEGFR2+CXCR4+ and CD34+CD45negVEGFR2+ICAM-1+ cells than healthy individuals. These changes were paralleled by early symptoms of nephropathy, that is, lower glomerular filtration rate (GFR) values and borderline micro albuminuria. Our results indicate that an elevation in the number of less differentiated progenitors may be a mechanism compensating for defects of migration and adhesion, present in a more differentiated subset.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Delva P, Degana M, Vallerioa P, Arosiob E, Minuza P, Amena G et al. Endothelial progenitor cells in patients with essential hypertension. J Hypertens 2007; 25: 127–132.

    Article  CAS  Google Scholar 

  2. Urbich C, Dimmeler S . Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95: 343–353.

    Article  CAS  Google Scholar 

  3. Fadini GP, Vigili de Kreutzenberg S, Coracina A, Baesso I, Agostini C, Tiengo A et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 2006; 27: 2247–2255.

    Article  CAS  Google Scholar 

  4. Gari M . Identification of circulating endothelial cells in peripheral blood. Res J Med Sci 2011; 5: 262–268.

    Google Scholar 

  5. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–967.

    Article  CAS  Google Scholar 

  6. Khakoo A, Finkel T . Endothelial progenitor cells. Annu Rev Med 2005; 56: 79–101.

    Article  CAS  Google Scholar 

  7. George A, Bangalore-Prakash P, Rajoria S, Suriano R, Shanmugam A, Mittelman A et al. Endothelial progenitor cell biology in disease and tissue regeneration. J Hematol Oncol 2011; 4: 24–31.

    Article  Google Scholar 

  8. Shantsila E, Watson T, Tse H-F, Lip G . New insights on endothelial progenitor cell subpopulations and their angiogenic properties. J Am Coll Cardiol 2008; 51: 669–671.

    Article  Google Scholar 

  9. Oliveras A, Soler MJ, Martinez-Estrada OM, Vazquez S, Marco-Feliu D, Vila JS et al. Endothelial progenitor cells are reduced in refractory hypertension. J Hum Hypertens 2008; 22: 183–190.

    Article  CAS  Google Scholar 

  10. Thuillez C, Richard V . Targeting endothelial dysfunction in hypertensive subjects. J Hum Hypertens 2005; 19: 21–25.

    Article  Google Scholar 

  11. Ferroni P, Basili S, Paoletti V, Davi G . Endothelial dysfunction and oxidative stress in arterial hypertension. Nutr Metab Cardiovasc Dis 2006; 16: 222–233.

    Article  CAS  Google Scholar 

  12. Pirro M, Schillaci G, Menecali C, Bagaglia F, Paltriccia R, Vaudo G et al. Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients. J Hypertens 2007; 25: 2093–2099.

    Article  CAS  Google Scholar 

  13. Ciuffetti G, Schillaci G, Innocente S, Lombardini R, Pasqualini L, Notaristefano S et al. Capillary rarefaction and abnormal cardiovascular reactivity in hypertension. J Hypertens 2003; 21: 2297–2303.

    Article  CAS  Google Scholar 

  14. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA . Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 1999; 34: 655–658.

    Article  CAS  Google Scholar 

  15. Antonios TFT, Singer DRJ, Markandu ND, Mortimer PS, MacGregor GA . Structural skin capillary rarefaction in essential hypertension. Hypertension 1999; 33: 998–1001.

    Article  CAS  Google Scholar 

  16. Li D, Liu Z, Wei J, Liu Y, Hu L . Contribution of endothelial progenitor cells to neovascularization. Int J Mol Med. 2012; 30: 1000–1006.

    Article  CAS  Google Scholar 

  17. Balaji S, King A, Crombleholme T, Keswani S . The role of endothelial progenitor cells in postnatal vasculogenesis: implications for therapeutic neovascularization and wound healing. Adv Skin Wound Care 2012; 6: 283–295.

    Google Scholar 

  18. Caiado F, Dias S . Endothelial progenitor cells and integrins: adhesive needs. Fibrogenesis Tissue Repair 2012; 5: 4.

    Article  CAS  Google Scholar 

  19. Bompais H, Chagraoui J, Canron X, Crisan M, Liu XH, Anjo A et al. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 2004; 103: 2577–2584.

    Article  CAS  Google Scholar 

  20. Pelosi E, Castelli G, Martin-Padura I, Bordoni V, Santoro S, Conigliaro A et al. Human haemato-endothelial precursors: cord blood CD34+ cells produce haemogenic endothelium. PLoS ONE 2012; 7: e51109.

    Article  CAS  Google Scholar 

  21. Rodriguez-Carrio J, De Paz B, Lopez P, Prado C, Alperi-Lopez M, Ballina-Garcia F et al. IFNa serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients. PLoS ONE 2014; 9: e86069.

    Article  Google Scholar 

  22. Mula-Abed WA, Al Rasadi K, Al-Riyami D . Estimated glomerular filtration rate (eGFR): a serum creatinine-based test for the detection of chronic kidney disease and its impact on clinical practice. Oman Med J 2012; 2: 108–113.

    Article  Google Scholar 

  23. Kidney Disease Improving Global Outcomes (KDIGO). Clinical Practice Guidelines for Evaluation and Management Chronic Kidney Disease. Kidney Inter. Suppl. 2013; 3: 1–150.

    Article  Google Scholar 

  24. Grundy SM, Becker D, Clark LT, Cooper RS, Denke MA, Howard J et al. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143–3421.

    Article  Google Scholar 

  25. Leone A, Valgimigli M, Giannico M, Zaccone V, Perfetti M, D’Amario D et al. From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. Eur Heart J 2009; 30: 890–899.

    Article  Google Scholar 

  26. Basile D, Yoder M . Circulating and tissue resident endothelial progenitor cells. J Cell Physiol 2014; 229: 10–16.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Mandraffino G, Sardo MA, Riggio S, Loddo S, Imbalzano E, Alibrandi A et al. Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness. Hypertens Res 2011; 34: 876–883.

    Article  CAS  Google Scholar 

  28. Cohen KS, Cheng S, Larson MG, Cupples LA, McCabe EL, Wang YA et al. Circulating CD34+ progenitor cell frequency is associated with clinical and genetic factors. Blood 2013; 121: 50–56.

    Article  Google Scholar 

  29. Fadini GP, de Kreutzenberg SV, Coracina A, Baesso I, Agostini C, Tiengo A et al. Circulating CD34 cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 2006; 27: 2247–2255.

    Article  CAS  Google Scholar 

  30. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: 1–7.

    Article  Google Scholar 

  31. Fritzenwanger M, Lorenz F, Jung C, Fabris M, Thude H, Barz D et al. Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure. Eur J Med Res 2009; 17: 11311–11317.

    Google Scholar 

  32. Mandraffino G, Imbalzano E, Sardo MA, D’Ascola A, Mamone F, Gullo A et al. Circulating progenitor cells in hypertensive patients with different degrees of cardiovascular involvement. J Hum Hypertens 2014; 28 (9): 543–550.

    Article  CAS  Google Scholar 

  33. Sainz J, Sata M . CXCR4, a key modulator of vascular progenitor cells. Arterioscler Thromb Vasc Biol 2007; 27: 263–265.

    Article  CAS  Google Scholar 

  34. Butthep P, Rummavas S, Wisedpanichkij R, Jindadamrongwech S, Fucharoen S, Bunyaratvej A . Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia. Am J Hematol 2002; 70: 100–106.

    Article  CAS  Google Scholar 

  35. Krenning G, Dankers P, Drouven J, Waanders F, Franssen C, vanLuyn M et al. Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease. J Physiol Renal Physiol 2009; 6: 1314–1322.

    Article  Google Scholar 

Download references

Acknowledgements

The paper was subsided by the grant of National Science Centre Nr 2011/01/B/NZ5/00345.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Skrzypkowska.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Skrzypkowska, M., Myśliwska, J., Słomiński, B. et al. Quantitative and functional characteristics of endothelial progenitor cells in newly diagnosed hypertensive patients. J Hum Hypertens 29, 324–330 (2015). https://doi.org/10.1038/jhh.2014.85

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2014.85

This article is cited by

Search

Quick links